Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III ...
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the combination regimen of VENCLEXTA® (venetoclax) and ...
Commercial adoption of the Galleri multi-cancer early detection test remained a bright spot, with more than 185,000 tests ...
Key opportunities in the pancreatic cancer market include advancing novel therapies such as masitinib, pamrevlumab, and quemliclustat, alongside strategic collaborations and FDA designations to foster ...
As with randomization, if allocation to the study drug is not carried out in accordance with the protocol, the entire study ...
Investing.com -- Evommune Inc. (NYSE:EVMN) stock soared 64% after the clinical-stage biotechnology company announced positive top-line results from its Phase 2a trial evaluating EVO301 in patients ...
Diabetes drug metformin may reduce the risk of a serious eye disease (macular degeneration) by 37%, helping diabetes patients with diabetes and save their sight.
Solvej Balle, trans. from the Danish by Jennifer Russell and Sophia Hersi Smith. New Directions, $15.95 trade paper (176p) ISBN 978-0-8112-3841-0 Balle picks up her remarkable seven-part saga of a ...
Abstract: Treatment planning, which is a critical component of the radiotherapy workflow, is typically carried out by a medical physicist in a time-consuming trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results